MARCKS and inflammatory breast carcinoma: But yet, our results suggest that MARCKS overexpression might in part explain the poor prognosis of IBC and that MARCKS, as an oncogene associated with poor MFS in IBC, might represent a new potential target for therapeutic intervention.